|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 481.69 USD | -0.76% |
|
-8.88% | +6.44% |
| 08:17pm | UBS Adjusts Vertex Pharmaceuticals Price Target to $585 From $545, Maintains Buy Rating | MT |
| 09/07 | RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570 | MT |
Chart calendar Vertex Pharmaceuticals Incorporated
Upcoming events on Vertex Pharmaceuticals Incorporated
| 04/08/2026 | Earnings release - Q2 2026 | |
| 04/08/2026 | Earnings presentation | 02:00 am |
Past events on Vertex Pharmaceuticals Incorporated
| 13/05/2026 | Présentation aux Actionnaires / Analystes | 06:30 pm |
| 13/05/2026 | Annual General Meeting | 06:30 pm |
| 05/05/2026 | Earnings release - Q1 2026 | |
| 05/05/2026 | Earnings presentation | 02:00 am |
| 13/02/2026 | Earnings presentation | 03:00 am |
| 13/02/2026 | Earnings release - Q4 2025 | |
| 09/11/2025 | Information meeting | 06:30 am |
| 04/11/2025 | Earnings release - Q3 2025 | |
| 04/11/2025 | Earnings presentation | 03:00 am |
| 05/08/2025 | Earnings release - Q2 2025 | |
| 05/08/2025 | Earnings presentation | 02:00 am |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9 869 9 861 0.08% | 11 020 10 879 1.3% | 12 001 11 982 0.16% | 13 057 | 14 316 | 15 930 |
|
EBITDA Million USD | Released Forecast Spread | 4 556 4 734 -3.75% | 903 882 2.4% | 5 473 5 588 -2.05% | 5 789 | 6 670 | 7 645 |
|
EBIT Million USD | Released Forecast Spread | 4 375 4 461 -1.94% | 696 678 2.65% | 5 263 5 349 -1.61% | 5 539 | 6 275 | 7 318 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 380 4 415 -0.8% | 249 289 -13.9% | 4 643 4 754 -2.32% | 5 468 | 6 312 | 7 631 |
|
Net income Million USD | Released Forecast Spread | 3 620 3 574 1.28% | -536 -419 -27.93% | 3 953 3 977 -0.61% | 4 499 | 5 068 | 6 014 |
|
EPS USD | Released Forecast Spread | 13,9 13,7 1.52% | -2,08 -1,59 -30.82% | 15,3 15,3 -0.13% | 17,5 | 19,6 | 23,1 |
| Announcement Date | 05/02/24 | 10/02/25 | 12/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 772 2 690 3.03% | 2 912 2 781 4.72% | 2 770 2 861 -3.17% | 2 965 2 907 2% | 3 076 3 059 0.56% | 3 190 3 175 0.48% | 2 987 2 998 -0.36% | 3 217 | 3 357 | 3 493 | 3 330 | 3 523 | 3 715 | 3 819 |
|
EBITDA Million USD | Released Forecast Spread | 1 360 1 305 4.24% | 1 245 1 212 2.75% | 1 231 1 313 -6.18% | 1 377 1 336 3.09% | 1 439 1 371 4.95% | 1 426 1 486 -4.04% | 1 366 1 333 2.49% | 1 353 | 1 490 | 1 556 | 1 512 | 1 537 | 1 709 | 1 885 |
|
EBIT Million USD | Released Forecast Spread | 1 307 1 213 7.72% | 1 198 1 189 0.79% | 1 183 1 301 -9.08% | 1 325 1 290 2.74% | 1 385 1 383 0.16% | 1 370 1 471 -6.83% | 1 310 1 246 5.2% | 1 369 | 1 413 | 1 452 | 1 547 | 1 545 | 1 672 | 1 794 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 224 1 114 9.87% | 1 137 1 168 -2.68% | 730 1 201 -39.18% | 1 283 1 232 4.15% | 1 299 1 333 -2.55% | 1 331 1 423 -6.48% | 1 253 1 220 2.66% | 1 357 | 1 410 | 1 444 | 1 339 | 1 440 | 1 509 | 1 594 |
|
Net income Million USD | Released Forecast Spread | 1 045 941 11.09% | 913 927 -1.47% | 646 963 -32.9% | 1 033 985 4.81% | 1 083 1 057 2.43% | 1 191 1 193 -0.13% | 1 031 963 7.07% | 1 122 | 1 165 | 1 185 | 1 143 | 1 174 | 1 269 | 1 374 |
|
EPS USD | Released Forecast Spread | 4,01 3,63 10.45% | 3,50 3,66 -4.27% | 2,49 3,76 -33.73% | 3,99 3,72 7.33% | 4,20 4,11 2.31% | 4,65 4,58 1.43% | 4,02 3,83 4.83% | 4,42 | 4,48 | 4,68 | 4,03 | 4,51 | 4,99 | 5,28 |
| Announcement Date | 04/11/24 | 10/02/25 | 05/05/25 | 04/08/25 | 03/11/25 | 12/02/26 | 04/05/26 | - | - | - | - | - | - | - |
| 14/07/2026 |  | Ex-dividend date - 0.052 CNY | 09:30 am |
| 15/07/2026 | | Earnings release - Q2 2026 | 04:15 pm |
| 15/07/2026 | | Earnings presentation | 06:00 pm |
| 15/07/2026 | | Ex-dividend date - 1.73 USD | 09:30 am |
| 15/07/2026 | | Earnings release - Q2 2026 | |
| 15/07/2026 | | Earnings presentation | 05:30 pm |
| 15/07/2026 | | Extraordinary General Meeting | 12:00 pm |
| 15/07/2026 | | Ex-dividend date - 0.05 CNY | 09:30 am |
| 15/07/2026 | | Ex-dividend date - 0.2 CNY | 09:30 am |
| 15/07/2026 | | Ex-dividend date - 0.057 CNY | 09:30 am |
Past sector events for Vertex Pharmaceuticals Incorporated
| Today | | Ex-dividend date - 0.77711 EUR | 09:30 am |
| 11/07/2026 | | Board of Directors Meeting | 12:30 pm |
| 10/07/2026 | | Ex-dividend date - 8 INR | 09:30 am |
| 10/07/2026 | | Extraordinary General Meeting | 11:30 am |
| 10/07/2026 | | Extraordinary General Meeting | 11:30 am |
| 10/07/2026 | | Ex-dividend date - 0.17248 HKD | 09:30 am |
| 10/07/2026 | | Annual General Meeting | 11:00 am |
| 10/07/2026 | | Présentation aux Actionnaires / Analystes | 11:00 am |
| 10/07/2026 | | Board of Directors Meeting | |
| 09/07/2026 | | Information meeting | 04:30 pm |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- Calendar Vertex Pharmaceuticals Incorporated
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
